PDX model details
| PDX ID |
27.1A Cx |
| Host Strain(and Source) |
NSG Source: Monash University |
| Host Strain Immune system Humanized |
NO |
| Host Type |
Castrate |
| Graft Site |
Subcutaneous |
Current Generation (* indicates number of generations grown in Castrate host) |
29 (8*) |
| Average PDX Generation Time (days +/- SEM) |
82 ± 8 |
| Tumour preparation |
Tumor solid |
| Tumour Characterization Technology |
Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq |
| Tumour confirmed not to be of Mouse/EBV origin |
Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC |
| Passage QA performed |
Routine QA every 2-3 passages |
| Associated meta data |
| PDX model availability |
Yes (fixed, frozen or cryopreserved tissue) |
| Governance restriction for distribution |
Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements |
| Pubmed ID |
34413304; 30049486 |
| |
|
| Markers |
27.1A Cx |
| AR |
Y |
| PSA |
Y |
| PSMA |
Y |
| NE |
N |
| ERG |
N |
This heatmap displays the call type of curated CNVs in the presented samples.
This heatmap displays the call type of CNVs in commonly occurred samples.
This table displays curated CNVs
|
PDX ID
|
Gene Symbol
|
CNV Log2
|
CNV Copy
|
CNV Call
|
Experiments name
|
Platform
|
Reference genome
|
| 27.1A Cx |
SETDB1 |
0.586547 |
3.0033 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
MET |
0.584798 |
2.99966 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
BRAF |
0.584798 |
2.99966 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
EZH2 |
0.584798 |
2.99966 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
KMT2C |
0.584798 |
2.99966 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
PAX6 |
-1.02752 |
0.981105 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
MGA |
-0.931673 |
1.0485 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
CDH1 |
-0.988068 |
1.0083 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
ZFHX3 |
-0.988068 |
1.0083 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
FANCA |
-0.988068 |
1.0083 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
SMAD2 |
-0.96199 |
1.0267 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
MBD1 |
-0.96199 |
1.0267 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
CHD1 |
-26.9288 |
0.0000000157 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
RB1 |
-28.0016 |
0.00000000744 |
homdel |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
| 27.1A Cx |
AR |
-4.02605 |
0.0613816 |
GSR |
MURAL Prostate Cancer PDX collection |
Targeted Twist Panel |
hg19 |
Clinical Information
| Sample Number |
27.1A |
| Sample Site |
Brain |
| Sample source |
Autopsy |
| Pathology Tumour Diagnosis |
Adenocarcinoma |
| Gleason Score |
None |
| Primary Gleason Score |
None |
| Secondary Gleason Score |
None |
| Tertiary Gleason Score |
None |
| ISUP Grade Group |
|
| Tumour Grade |
|
| D'Amico Risk Classification |
|
| Tumour Volume (in cc) |
0.0 |
| Treatment Prior to Specimen Collection |
ADT, docetaxel, abiraterone |
| |
|
Patient Information
| Patient Number |
27 |
| Sex |
Male |
| Diagnosis |
Prostate Cancer |
| PSA at diagnosis (ng/mL) |
42 |
| Consent to share data |
|
| |
|
This heatmap displays the mutations of curated sequence variants.
Download
This table displays curated sequence variants
|
PDX ID
|
Gene Symbol
|
Depth
|
ALT_FREQ
|
Consequence
|
Exon
|
GnomAD_AF
|
CADD_PHRED
|
Clinvar_clnsig
|
Platform
|
Experiments Name
|
Reference
|
Library Type
|
Instrument Type
|
| 27.1A Cx |
PCDH11X |
187 |
1.0 |
missense_variant |
'2/7 |
. |
22.9 |
-
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
TH |
372 |
0.61 |
start_lost |
'1/14 |
. |
21.5 |
-
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
TH |
372 |
0.61 |
start_lost |
'1/14 |
. |
21.5 |
-
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
LHFPL3 |
516 |
0.53 |
missense_variant |
'1/5 |
. |
26.7 |
-
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
SON |
395 |
0.51 |
missense_variant |
'3/12 |
. |
25.4 |
-
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
IGF2R |
655 |
0.39 |
missense_variant |
'16/48 |
3.28E-05 |
24 |
-
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
NF1 |
464 |
0.28 |
stop_gained |
'40/58 |
. |
38 |
Pathogenic
|
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
| 27.1A Cx |
AR |
— |
— |
GSR |
— |
— |
— |
— |
Targeted Twist Panel |
MURAL Prostate Cancer PDX collection |
hg19 |
paired |
NextSeq 500 |
No information in Gene expression
No information in Drug dosing Table